Summary
48 / 100 · Bulios Score
What speaks for it
- It holds more cash than debt: RM 953.4M against RM 38.7M.
- The share price is below the Bulios Fair Price.
- Analysts expect revenue to grow by 20% this fiscal year.
What to watch
- Revenue fell by 9.4% a year over the last 3 years.
- It cut its dividend by 76% last year.
- It earns only 4.7 MYR a year on every 100 MYR of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 10.3 MYR for 1 MYR of yearly profit. Over the last five years it was 72.5 MYR on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (MYR)
Diluted EPS (MYR)
- Analyst estimate
Revenue fell by 14% a year over 5 years. Over the last 3 years it fell by 9.4% a year. For the next fiscal year analysts expect revenue to grow by 20%. Earnings per share fell by 1.1% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 MYR of revenue goes
- Cost of sales 92 MYR
- Sales and administration 19 MYR
- Taxes and other 1.1 MYR
- Net profit 9.8 MYR
Net profit, industry median (Medical - Instruments & Supplies) 7.7 MYR
Out of every 100 MYR of revenue, 9.8 MYR is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 5.19%
- Paid out of profit
- 53%
You receive $0.01 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.